Stock Scorecard
Stock Summary for Verona Pharma Plc (VRNA) - $105.56 as of 8/22/2025 8:51:26 PM EST
Total Score
6 out of 30
Safety Score
40 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for VRNA
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for VRNA
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for VRNA
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for VRNA
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for VRNA (40 out of 100)
| Stock Price Rating (Max of 10) | 10 |
| Historical Stock Price Rating (Max of 10) | 4 |
| Stock Price Trend (Max of 10) | 10 |
| Book Value (Max of 10) | 3 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 2 |
| Analyst Strong Buy Ratings (Max of 5) | 0 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 3 |
| Trading Volume (Max of 10) | 8 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for VRNA
Financial Details for VRNA
Company Overview |
|
|---|---|
| Ticker | VRNA |
| Company Name | Verona Pharma Plc |
| Country | USA |
| Description | Verona Pharma plc, a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company is headquartered in London, the United Kingdom. |
| Sector Name | LIFE SCIENCES |
| Industry Name | PHARMACEUTICAL PREPARATIONS |
| Most Recent Quarter | 6/30/2025 |
| Next Earnings Date | 11/11/2025 |
Stock Price History |
|
| Last Day Price | 105.56 |
| Price 4 Years Ago | 6.72 |
| Last Day Price Updated | 8/22/2025 8:51:26 PM EST |
| Last Day Volume | 974,700 |
| Average Daily Volume | 3,322,813 |
| 52-Week High | 105.85 |
| 52-Week Low | 24.50 |
| Last Price to 52 Week Low | 330.86% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 40.56 |
| Sector PE | 58.53 |
| 5-Year Average PE | 10.32 |
| Free Cash Flow Ratio | 20.50 |
| Industry Free Cash Flow Ratio | 15.42 |
| Sector Free Cash Flow Ratio | 30.30 |
| Current Ratio Most Recent Quarter | 10.71 |
| Total Cash Per Share | 5.15 |
| Book Value Per Share Most Recent Quarter | 3.24 |
| Price to Book Ratio | 32.77 |
| Industry Price to Book Ratio | 29.05 |
| Sector Price to Book Ratio | 26.66 |
| Price to Sales Ratio Twelve Trailing Months | 40.56 |
| Industry Price to Sales Ratio Twelve Trailing Months | 25.49 |
| Sector Price to Sales Ratio Twelve Trailing Months | 13.25 |
| Analyst Buy Ratings | 1 |
| Analyst Strong Buy Ratings | 0 |
Share Statistics |
|
| Total Shares Outstanding | 84,979,000 |
| Market Capitalization | 8,970,383,240 |
| Institutional Ownership | 94.52% |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 0.00% |
| Annual Earnings Growth | -218.96% |
| Reported EPS 12 Trailing Months | -1.04 |
| Reported EPS Past Year | 0.12 |
| Reported EPS Prior Year | -1.81 |
| Net Income Twelve Trailing Months | -81,187,000 |
| Net Income Past Year | -173,418,000 |
| Net Income Prior Year | -54,369,000 |
| Quarterly Revenue Growth YOY | 0.00% |
| 5-Year Revenue Growth | 609.54% |
| Operating Margin Twelve Trailing Months | 12.90% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 438,016,000 |
| Total Cash Past Year | 399,757,000 |
| Total Cash Prior Year | 271,772,000 |
| Net Cash Position Most Recent Quarter | 195,582,000 |
| Net Cash Position Past Year | 279,416,000 |
| Long Term Debt Past Year | 120,341,000 |
| Long Term Debt Prior Year | 48,374,000 |
| Total Debt Most Recent Quarter | 242,434,000 |
| Equity to Debt Ratio Past Year | 0.63 |
| Equity to Debt Ratio Most Recent Quarter | 0.53 |
| Total Stockholder Equity Past Year | 204,559,000 |
| Total Stockholder Equity Prior Year | 249,283,000 |
| Total Stockholder Equity Most Recent Quarter | 278,273,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | -73,606,013 |
| Free Cash Flow Per Share Twelve Trailing Months | -0.87 |
| Free Cash Flow Past Year | -122,783,000 |
| Free Cash Flow Prior Year | -50,222,004 |
Options |
|
| Put/Call Ratio | 3.00 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 1.47 |
| MACD Signal | 1.92 |
| 20-Day Bollinger Lower Band | 52.95 |
| 20-Day Bollinger Middle Band | 86.91 |
| 20-Day Bollinger Upper Band | 120.86 |
| Beta | 0.12 |
| RSI | 72.70 |
| 50-Day SMA | 61.24 |
| 150-Day SMA | 32.46 |
| 200-Day SMA | 25.85 |
System |
|
| Modified | 8/21/2025 2:12:43 PM EST |